Advanced search
1 file | 277.90 KB Add to list

18F-FCho PET and MRI for the prediction of response in glioblastoma patients according to the RANO criteria

Julie Bolcaen (UGent) , Marjan Acou (UGent) , Tom Boterberg (UGent) , Christian Vanhove (UGent) , Filip De Vos (UGent) , Caroline Van den Broecke (UGent) , Roel Van Holen (UGent) , Karel Deblaere (UGent) and Ingeborg Goethals (UGent)
Author
Organization
Keywords
fluorine-18 fluoromethylcholine, glioblastoma, MRI, PET, therapy response, POSITRON-EMISSION-TOMOGRAPHY, NEWLY-DIAGNOSED GLIOBLASTOMA, RECURRENT MALIGNANT GLIOMA, HIGH-GRADE GLIOMAS, PROSTATE-CANCER, O-(2-F-18-FLUOROETHYL)-L-TYROSINE PET, DELAYED INTERVALS, TUMOR, BEVACIZUMAB, MULTIFORME

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 277.90 KB

Citation

Please use this url to cite or link to this publication:

MLA
Bolcaen, Julie, et al. “18F-FCho PET and MRI for the Prediction of Response in Glioblastoma Patients According to the RANO Criteria.” NUCLEAR MEDICINE COMMUNICATIONS, vol. 38, no. 3, 2017, pp. 242–49, doi:10.1097/mnm.0000000000000638.
APA
Bolcaen, J., Acou, M., Boterberg, T., Vanhove, C., De Vos, F., Van den Broecke, C., … Goethals, I. (2017). 18F-FCho PET and MRI for the prediction of response in glioblastoma patients according to the RANO criteria. NUCLEAR MEDICINE COMMUNICATIONS, 38(3), 242–249. https://doi.org/10.1097/mnm.0000000000000638
Chicago author-date
Bolcaen, Julie, Marjan Acou, Tom Boterberg, Christian Vanhove, Filip De Vos, Caroline Van den Broecke, Roel Van Holen, Karel Deblaere, and Ingeborg Goethals. 2017. “18F-FCho PET and MRI for the Prediction of Response in Glioblastoma Patients According to the RANO Criteria.” NUCLEAR MEDICINE COMMUNICATIONS 38 (3): 242–49. https://doi.org/10.1097/mnm.0000000000000638.
Chicago author-date (all authors)
Bolcaen, Julie, Marjan Acou, Tom Boterberg, Christian Vanhove, Filip De Vos, Caroline Van den Broecke, Roel Van Holen, Karel Deblaere, and Ingeborg Goethals. 2017. “18F-FCho PET and MRI for the Prediction of Response in Glioblastoma Patients According to the RANO Criteria.” NUCLEAR MEDICINE COMMUNICATIONS 38 (3): 242–249. doi:10.1097/mnm.0000000000000638.
Vancouver
1.
Bolcaen J, Acou M, Boterberg T, Vanhove C, De Vos F, Van den Broecke C, et al. 18F-FCho PET and MRI for the prediction of response in glioblastoma patients according to the RANO criteria. NUCLEAR MEDICINE COMMUNICATIONS. 2017;38(3):242–9.
IEEE
[1]
J. Bolcaen et al., “18F-FCho PET and MRI for the prediction of response in glioblastoma patients according to the RANO criteria,” NUCLEAR MEDICINE COMMUNICATIONS, vol. 38, no. 3, pp. 242–249, 2017.
@article{8502500,
  author       = {{Bolcaen, Julie and Acou, Marjan and Boterberg, Tom and Vanhove, Christian and De Vos, Filip and Van den Broecke, Caroline and Van Holen, Roel and Deblaere, Karel and Goethals, Ingeborg}},
  issn         = {{0143-3636}},
  journal      = {{NUCLEAR MEDICINE COMMUNICATIONS}},
  keywords     = {{fluorine-18 fluoromethylcholine,glioblastoma,MRI,PET,therapy response,POSITRON-EMISSION-TOMOGRAPHY,NEWLY-DIAGNOSED GLIOBLASTOMA,RECURRENT MALIGNANT GLIOMA,HIGH-GRADE GLIOMAS,PROSTATE-CANCER,O-(2-F-18-FLUOROETHYL)-L-TYROSINE PET,DELAYED INTERVALS,TUMOR,BEVACIZUMAB,MULTIFORME}},
  language     = {{eng}},
  number       = {{3}},
  pages        = {{242--249}},
  title        = {{18F-FCho PET and MRI for the prediction of response in glioblastoma patients according to the RANO criteria}},
  url          = {{http://doi.org/10.1097/mnm.0000000000000638}},
  volume       = {{38}},
  year         = {{2017}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: